Movement Disorders

Panelists look ahead in the management of advanced Parkinson disease and discuss the promise of different investigational therapies.

A discussion about the benefits of a multidisciplinary evaluation for patients with advanced Parkinson disease who are potential candidates for device-assisted therapy.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending August 6, 2021.

Homeostatic equilibrium was achieved with CNM-Au8 across essential energetic metabolites, including adenosine triphosphate, intracellular phosphorous, phosphocholine, and phosphorylation potential index.

The model discovered nonsequential, overlapping disease progression trajectories, supporting the use of nondeterministic disease progression models.

Here's what is coming soon to NeurologyLive.

Michael J. Soileau, MD, discusses the challenges of starting a device-assisted therapy in patients with advanced Parkinson disease.

An advanced Parkinson disease expert explains how to discuss the different device-assisted therapy options with patients.

AC Immune, the company presenting the data at the 2021 AAIC meeting, also recently acquired an a-syn vaccine, Affiris PD01.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending July 30, 2021.

The label now includes the use of ultrasound as a muscle localization technique in adults with spasticity, and includes muscles of the elbow, forearm, hand, and thumb.

Patients with neurological sequelae from COVID-19 were significantly more likely to die before discharge (22.2%) compared with non-neuro-COVID patients (14.4%).

Many applicants referenced an early interest and exposure to neurology, often describing their first courses in neurology sparking their desire to learn more about how the brain works.

Here's what is coming soon to NeurologyLive.

A discussion about when a clinician should consider discussing a device-assisted therapy with a patient with advanced Parkinson disease.

A discussion about when a clinician should consider discussing a device-assisted therapy with a patient with advanced Parkinson disease.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending July 23, 2021.

Basis for the approval was the SENZA-PDN randomized controlled trial, which showed the system’s ability to substantially sustain pain relief and improve health-related quality of life.

Here's what is coming soon to NeurologyLive.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending July 15, 2021.

Experts discuss their personal experiences using technology and devices in advanced Parkinson disease management and identify patients that are adequately controlled with therapy.

Considerations of gastroparesis in patients with advanced Parkinson disease.

Here's what is coming soon to NeurologyLive.

Neurology News Network for the week ending July 10, 2021.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending July 9, 2021.

Analyses suggest treatment of Parkinson disease with amantadine (Gocovri; Adamas) may improve freezing and tremor, as well as other M-EDLs.

The effect pridopidine had on reducing mutant HTT-induced endoplasmic reticulum stress via the activation of sigma-1 receptor provided additional evidence of its therapeutic potential.

Experts discuss different strategies to manage concerns relating to advanced Parkinson disease including patient education.

A discussion about how to educate and speak with patients with advanced Parkinson disease.

Here's what is coming soon to NeurologyLive.